Background/Aims: Arteritis is an inflammatory disease of the vascular wall leading to ischemia and vascular occlusion. Complications of arteritis include anemia, which could, at least in theory, result from suicidal erythrocyte death or eryptosis, which is characterized by erythrocyte shrinkage and phosphatidylserine (PS) exposure at the erythrocyte surface. Cellular mechanisms involved in the stimulation of eryptosis include increased cytosolic Ca 2+ -concentration ([Ca 2+ ] i ), oxidative stress and ceramide formation. The present study explored whether and how arteritis influences eryptosis. Methods: Blood was drawn from patients suffering from arteritis (n=17) and from healthy volunteers (n=21). PS exposure was estimated from annexin V-binding, erythrocyte volume from forward scatter, [Ca 2+ ] i from Fluo3-fluorescence, reactive oxygen species (ROS) from DCFDA fluorescence and ceramide abundance from FITC-conjugated antibody binding in flow cytometry. The patients suffered from anemia despite 2.8±0.4% reticulocytes. Results: The percentage of PS-exposing erythrocytes was significantly higher in patients (1.1±0.1%) than in healthy volunteers (0.3±0.1%). The increase in PS exposure was paralleled by increase in oxidative stress and [Ca 2+ ] i but not by significant changes of ceramide abundance. Erythrocyte PS exposure and ROS production were significantly enhanced in erythrocytes exposed to patient plasma as compared to exposure to plasma from healthy volunteers. Conclusion: Arteritis is associated with enhanced eryptosis due to increased [Ca 2+ ] i and oxidative stress. The eryptosis contributes to or even accounts for the anemia in those patients. As eryptotic erythrocytes adhere to endothelial cells of the vascular wall, they could impede microcirculation and thus contribute to vascular occlusion.
Introduction
Arteritis, an inflammatory disease of the vascular wall, may eventually lead to vascular occlusion with severe injury of the affected organs [1] . The vascular occlusion is considered to be, at least in part, due to activation of blood platelets [2] . Further complications of arteritis include anemia [1, [3] [4] [5] . At least in theory, anemia during arteritis may result from stimulation of eryptosis, the suicidal death of erythrocytes characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine exposure at the erythrocyte surface [6] . Phosphatidylserine exposing erythrocytes are rapidly cleared from circulating blood and accelerated eryptosis is a common cause of anemia [6] . As phosphatidylserine-exposing erythrocytes bind to the surface of endothelial cells, they may impede microcirculation and thus contribute to vascular occlusion [6] .
Cellular mechanisms involved in the stimulation of eryptosis include increased cytosolic Ca 2+ concentration ([Ca 2+ ] i ) due to Ca 2+ entry through Ca
2+
-permeable cation channels [6, 7] , oxidative stress [6] , ceramide formation [6] , energy depletion [6] , caspase activation [6] and deranged activity of a variety of kinases [6] . Enhanced eryptosis is common and contributes to the anemia of a variety of clinical conditions including chronic kidney disease (CKD), hemolytic-uremic syndrome, diabetes, hepatic failure, malignancy, sepsis, sickle-cell disease, and Wilsons disease [6, [8] [9] [10] .
The present study explored, whether arteritis is associated with enhanced phosphatidylserine exposure of circulating erythrocytes and, if so, to identify the cellular mechanisms possibly involved.
Materials and Methods

Patients, erythrocytes and treatments
Seventeen patients (13 ♀, 4 ♂, age 65.1 ± 3.1 years) with arteritis were enrolled in the study. The clinical diagnosis and patient characteristics are shown in Table 1A . The patients suffered from anemia (Table 1B) . Blood was drawn from patients and from age and sex matched healthy volunteers. The study was approved by the ethics committee of the University of Tübingen (184/2003V). Both, volunteers and patients provided written informed consent. In order to isolate the erythrocytes, whole blood was centrifuged at 120 x g for 20 min at 23 °C and the platelets and leukocytes-containing supernatant was disposed. Measurements were made in freshly isolated erythrocytes or in erythrocytes (O -blood group) from healthy young individuals incubated in vitro with 500 µl plasma from patients or healthy volunteers at a hematocrit of 0.4% for 24 hours. For all measurements 50.000 cells were counted.
FACS analysis of annexin V-binding and forward scatter
In order to determine annexin-V-binding, 2 µl of freshly drawn blood were mixed in 500 µl Ringer solution containing 5 mM CaCl 2 , subsequently stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in Ringer solution containing 5 mM CaCl 2 at 37°C for 15 min under protection from light. The annexin V abundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding cells and control cells. The same threshold was used for healthy erythrocytes and erythrocytes from arteritis patients. A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters.
Reticulocyte count
For determination of the reticulocyte count, Lithium-Heparin-whole blood (2 μl) was added to 500 µl Retic-COUNT® (thiazole orange) reagent from Becton Dickinson. Samples were stained for 30 min at room temperature in the dark and flow cytometry was performed according to the manufacturer's instructions. Forward scatter (FSC), side scatter (SSC) and thiazole orange-fluorescence intensity (in FL-1) of the blood cells were determined. The number of Retic-COUNT positive reticulocytes was expressed as the percentage of the total gated erythrocyte population. Gating of erythrocytes was achieved by analysis of FSC vs. SSC dot plots using CellQuest software.
Measurement of intracellular Ca
2+
In order to quantify intracellular Ca 2+ concentration, 2 µl of freshly drawn blood were mixed in 500 µl Ringer solution containing 5 mM CaCl 2 , stained with Fluo-3/AM (5 µM; Biotium, Hayward, USA) and incubated at 37°C for 30 min. Ca 2+ -dependent fluorescence intensity was measured in FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur. Afterwards, the geomean of the Ca 2+ dependent fluorescence was determined.
Determination of ceramide formation
To determine ceramide abundance, a monoclonal antibody-based assay was used. Four µl erythrocytes were mixed in 1 ml Ringer. From the resulting cell suspension, 100 µl was centrifuged (1600 rpm for 3 mins at RT) and the erythrocytes were pelleted. Subsequently, cells were stained for 1 h at 37°C with 1 μg/ml anti-ceramide antibody (1:10 dilution; clone MID 15B4; Alexis, Grünberg, Germany) in phosphatebuffered saline (PBS) containing 0.1 % bovine serum albumin (BSA). After two washing steps with 100 µl PBS-BSA, cells were stained for 30 min with polyclonal fluorescein-isothiocyanate (FITC)-conjugated goat anti-mouse IgG and IgM specific antibody (1:50 dilution; BD Pharmingen, Hamburg, Germany) in PBS- 
Quantification of reactive oxygen species (ROS)
Oxidative stress was determined utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). Four µl erythrocytes were mixed in 1 ml Ringer. From the resulting cell suspension 150 µl was centrifuged (1600 rpm for 3 mins at RT). Cells were stained with DCFDA (10 µM; Sigma, Schnelldorf, Germany) in Ringer solution at 37°C for 30 min and then washed three times in 150 µl Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent fluorescence intensity was measured in FL-1 at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur. Subsequently, the geomean of the ROS-dependent fluorescence was determined. 
Confocal microscopy and immunofluorescence
Statistics
Data are expressed as arithmetic means ± SEM. Mann-Whitney test and Student´s t-test were performed to determine statistical significance between the two groups using Graph Pad Prism version 6.00 for Windows, GraphPad Software, La Jolla California USA; n denotes the number of individuals. P< 0.05 was considered significant.
Results
The present study explored the putative impact of arteritis on suicidal erythrocyte death. In a first step, we analyzed the differences in blood parameters of arteritis patients and healthy volunteers. As a result, erythrocyte count, hemoglobin concentration and hematocrit were significantly lower in arteritis patients as compared to healthy patients, suggesting that arteritis patients suffered from anemia (Fig. 1A,B,C) . The percentage of reticulocytes was significantly higher in the arteritis patients in comparison to healthy volunteers suggesting increased erythropoiesis in arteritis patients (Fig. 1 D) .
In a next step, we explored the extent of eryptosis in patients suffering from arteritis. The key hallmark of eryptosis is phosphatidylserine translocation to the erythrocyte surface. In order to identify phosphatidylserine exposing erythrocytes, annexin V positive cells were detected by confocal microscopy. As shown in Fig. 2 A, the number of phosphatidylserine exposing erythrocytes was higher in fresh blood drawn from arteritis patients compared to the healthy control group. The percentage of annexin V binding cells was in addition determined by FACS analysis. As illustrated in Fig. 2 C, the percentage of annexin V positive cells was significantly higher (about three times) in patients suffering from arteritis than in healthy volunteers. Eryptosis is typically paralleled by cell shrinkage. Accordingly, forward scatter was determined in flow cytometry as a measure of erythrocyte volume. The average forward scatter geomean was, however, not significantly different between erythrocytes from patients (516 ± 12 a.u., n = 15) and erythrocytes drawn from healthy volunteers (498 ± 5 a.u., n = 18).
Phosphatidylserine As phosphatidylserine translocation may further result from oxidative stress, reactive oxygen species in erythrocytes was determined utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA) fluorescence. As illustrated in Fig. 3C ,D, DCFDA-fluorescence was significantly higher in erythrocytes from freshly drawn blood of arteritis patients than in erythrocytes from freshly drawn blood of healthy volunteers.
As ceramide similarly stimulates phosphatidylserine translocation in erythrocytes, ceramide abundance was determined by FITC-labeled anti-ceramide antibodies. As a result, the ceramide abundance tended to be higher in erythrocytes from freshly drawn blood of arteritis patients (13.1 ± 0.8 a.u., n = 13) than in erythrocytes from freshly drawn blood of hours exposure to plasma from healthy volunteers (red area) and to plasma from arteritis patients (black line). B. Arithmetic means ± SEM of the percentage of annexin Vbinding erythrocytes from healthy volunteers exposed for 24 hours to plasma from healthy volunteers (n=18, white bar) and to plasma from arteritis patients (n=13, black from arteritis patients (black line). D. Arithmetic means ± SEM of DCFDA fluorescence in erythrocytes from freshly drawn blood of healthy volunteers (n=18, white bar) and from arteritis patients (n=13, black bar). * (P<0.05) and ** (P<0.01) indicate significant difference from healthy volunteers (unpaired t test). bar). C. Original histograms of DCFDA fluorescence of erythrocytes from healthy volunteers following a 24 hours exposure to plasma from healthy volunteers (red area) and to plasma from arteritis patients (black line). D. Arithmetic means ± SEM of DCFDA fluorescence in erythrocytes from healthy volunteers exposed for 24 hours to plasma from healthy volunteers (n=18, white bar) and from arteritis patients (n=13, black bar). *(P<0.05) indicates significant difference from healthy volunteers (unpaired t test).
healthy volunteers (11.9 ± 0.4 a.u., n = 18), a difference, however, not reaching statistical significance.
The present study further elucidated whether eryptosis is triggered by a blood-borne component. To this end, erythrocytes from healthy volunteers were exposed for 24 hours to plasma from either healthy volunteers or plasma from arteritis patients. As illustrated in Fig. 4A ,B, the percentage of annexin-V-binding erythrocytes from healthy volunteers was significantly higher following a 24 hours exposure to plasma from arteritis patients than following a 24 hours exposure to plasma from healthy volunteers. The average forward scatter of erythrocytes following exposure to plasma from arteritis patients tended to be lower (460 ± 14 a.u., n = 13) than following exposure to plasma from healthy volunteers (473 ± 12 a.u., n = 18), a difference, however, not reaching statistical significance.
The Fluo3 fluorescence and ceramide abundance in erythrocytes from healthy individuals were not significantly different between erythrocytes exposed to patient plasma and erythrocytes exposed to plasma from healthy volunteers (data not shown).
According to DCFDA fluorescence, ROS was significantly higher following exposure to plasma from arteritis patients than following exposure to plasma from healthy volunteers (Fig. 4C,D) . Thus, a plasma component in arteritis patients imposes oxidative stress on erythrocytes.
Discussion
The present study reveals that arteritis is associated with enhanced appearance of phosphatidylserine-exposing erythrocytes in circulating blood. Accordingly, arteritis leads to accelerated suicidal erythrocyte death or eryptosis.
The percentage of phosphatidylserine-exposing erythrocytes was about three times higher in freshly drawn blood from the patients as in blood drawn from healthy volunteers. As phosphatidylserine exposing erythrocytes are rapidly cleared form circulating blood [6] , a doubling of phosphatidylserine-exposing erythrocytes in circulating blood should decrease erythrocyte life span to half. If erythrocyte formation would not be enhanced, the reduction of erythrocyte life span to half would be expected to reduce the number of circulating erythrocytes by 50%. However, the anemia is followed by enhanced release of erythropoietin, which stimulates the formation of new erythrocytes. The enhanced erythropoiesis is apparent from the enhanced percentage of reticulocytes in circulating blood. Besides stimulating erythropoiesis, erythropoietin may enhance the susceptibility of erythrocytes for triggers of eryptosis, an effect, at least in theory, contributing to enhanced eryptosis in arteritis patients [11] .
The observed eryptosis in arteritis patients is, at least in part, the result of stimulation by a component in plasma, as treatment of erythrocytes from healthy individuals with plasma from arteritis patients triggered cell membrane scrambling with phosphatidylserine translocation. Possibly, eryptosis does not result from a single component, but may result from altered concentration of several blood components. Eryptosis is stimulated by a wide variety of small molecules including the inflammatory mediators prostaglandin E2 [38] and leukotriene [39] and enhanced eryptosis is observed in several clinical disorders [6, 8, 40] . Thus, stimulation of eryptosis in arteritis may result from systemic inflammation rather than from specific injury of the vascular wall. Future experiments may uncover some of the components contributing to the stimulation of eryptosis in arteritis.
The present observations further shed some light on the underlying cellular mechanisms participating in the stimulation of eryptosis. According to our observations, the stimulation of eryptosis is paralleled by increases in cytosolic Ca 2+ activity and involves oxidative stress but is not paralleled by increased ceramide abundance. Both, oxidative stress and ceramide are well known stimulators of eryptosis [6] . The present observations do, however, not rule out additional mechanisms participating in the triggering of eryptosis. Future experiments will be required to fully define the mechanisms underlying eryptosis in arteritis.
In addition to its effect on erythrocyte life span, the stimulation of phosphatidylserine translocation to the erythrocyte surface is expected to foster thrombosis and thus to interfere with microcirculation [6] . Phosphatidylserine-exposing erythrocytes adhere to the vascular wall due to interaction of erythrocytic phosphatidylserine with endothelial CXCL16/SR-PSO [41] . Erythrocyte adherence to the vascular wall is expected to interfere with blood flow [6, 41] . Moreover, phosphatidylserine-exposing erythrocytes trigger blood clotting [6, 42] . Phosphatidylserine exposing erythrocytes could activate the complement system [42, 43] leading to further stimulation of eryptosis [44] and aggravation of vascular inflammation [43] .
Conclusion
Arteritis is paralleled by stimulation of eryptosis, an effect at least partially due to increased cytosolic Ca 2+ activity and oxidative stress. Eryptosis could in turn lead to anemia, to further vascular inflammation and thus to further impairment of microcirculation. Thus, therapeutic considerations in the treatment of arteritis may include strategies to counteract eryptosis.
